Search Results - "Group, PROFILE Study"

Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trial.

Authors: Noor, Nurulamin M Davies, Neil Tahir, Warda et al.

Source: Journal of Crohn's & Colitis. Sep2025, Vol. 19 Issue 9, p1-12. 12p.